EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Differential Expression of Maternal Plasma microRNAs and Their Respective Gene Targets Can Predict Early Fetal Growth Restriction

Emmanuel Kolawole, Aparna Duggirala iD, Oscar Gronow, Agnieszka Lovett iD, Jiamiao Hu iD, Bee Kang Tan iD

Life · 24.01.2025 · 15 (2) · 167

DOI: 10.3390/life15020167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.01.2025. Verfasst von Emmanuel Kolawole und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Science and Engineering, Biomedical and Clinical Science Research Centre, University of Derby, Derby DE22 1GB, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetal growth restriction (FGR) is a condition where the fetus does not reach its genetically predetermined size, affecting 1 in 10 pregnancies and contributing to up to 50% of all stillbirths before 34 weeks of gestation. Current diagnostic methods primarily involve ultrasound and Doppler assessments, yet there is growing interest in identifying biomarkers for early diagnosis and improved management. This systematic review examined the role of microRNAs (miRNAs) in the pathogenesis of FGR, focusing on their potential as non-invasive biomarkers. MicroRNAs are small, non-coding RNAs that regulate gene expression. This review systematically assessed studies investigating the differential expression of miRNAs in maternal blood, serum, and plasma samples from FGR-affected pregnancies. A total of nine studies met the inclusion criteria, which showed the differential expression of a total of 48 miRNAs. miR-16-5p was consistently upregulated in multiple studies and trimesters. miR-590-3p and miR-206 were consistently upregulated in multiple trimesters. The common gene targets of these miRNAs are VEGF, PIGF, and MMP9. The downregulation of these genes contributes to impaired angiogenesis, trophoblast invasion, placental function, and fetal growth.

Schlagwörter

Stichwörter der Autor:innen

MMP9PIGFVEGFangiogenesisfetal growth restrictionmaternal bloodmicroRNAsnon-invasive diagnosisplasma

Autor:innen und Institutionen

  • College of Science and Engineering, Biomedical and Clinical Science Research Centre, University of Derby, Derby DE22 1GB, UK.
  • Department of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.

ORCID-Profile: Aparna Duggirala, Agnieszka Lovett, Jiamiao Hu, Bee Kang Tan

Zitieren

APA

Kolawole, E., Duggirala, A., Gronow, O., Lovett, A., Hu, J., & Tan, B. K. (2025). Differential Expression of Maternal Plasma microRNAs and Their Respective Gene Targets Can Predict Early Fetal Growth Restriction. Life, 15(2), 167. https://doi.org/10.3390/life15020167

Vancouver

Kolawole E, Duggirala A, Gronow O, Lovett A, Hu J, Tan BK. Differential Expression of Maternal Plasma microRNAs and Their Respective Gene Targets Can Predict Early Fetal Growth Restriction. Life. 2025;15(2):167. doi:10.3390/life15020167

BibTeX
@article{Kolawole2025,
  author = {Kolawole, Emmanuel and Duggirala, Aparna and Gronow, Oscar and Lovett, Agnieszka and Hu, Jiamiao and Tan, Bee Kang},
  title = {Differential Expression of Maternal Plasma microRNAs and Their Respective Gene Targets Can Predict Early Fetal Growth Restriction},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {167},
  doi = {10.3390/life15020167}
}
Kostenlos starten →